With the full-year 2025 earnings season coming to a close, certain sectors in healthcare performed strongly against the industry average.
In the latest GlobalData Healthcare Podcast, pharmaceutical editor Robert Barrie sits down with medical device reporter Ross Law to discuss the big growth drivers across the latest wave of financial results from drugmakers and medtech firms.
In the episode, the team covers revenue from companies such as Eli Lilly, AstraZeneca, Edwards Lifesciences, and Medtronic, amongst others.
These earnings reports come amid headwinds such as geopolitical shifts, pricing pressures, and patent losses.
